オカザキ ケン
OKAZAKI Ken
岡崎 賢 所属 医学部 医学科(東京女子医科大学病院) 職種 教授・基幹分野長 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Course and treatment of severe osteoporosis complicated by calciphylaxis: a case report. |
掲載誌名 | 正式名:JBMR plus 略 称:JBMR Plus ISSNコード:24734039/24734039 |
掲載区分 | 国外 |
巻・号・頁 | 9(1),pp.ziae154 |
著者・共著者 | Tominaga Ayako, Wada Keiji, Kato Yoshiharu, Okazaki Ken |
担当区分 | 最終著者 |
発行年月 | 2025/01 |
概要 | Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare disorder with many unknown treatment and diagnostic aspects. It is characterized by calcification and thrombosis of small blood vessels. This disease leads to progressive skin calcification, necrotizing ulcers, and infections and is associated with a high mortality rate. Although primarily affected sites tend to be on skin, those affecting bones are also significant. We report a case of CUA complicated with rapidly progressing multiple vertebral fractures and severe osteoporosis. The patient experienced a series of five vertebral fractures within 5 months after hospitalization, and blood tests revealed abnormally high levels of bone resorption marker bone-type tartrate-resistant acid phosphatase (TRACP-5b). Consequently, intravenous sodium thiosulfate and hyperbaric oxygen therapy were administered for the treatment of skin lesions caused by calciphylaxis, and brace therapy and denosumab treatment were initiated for vertebral fractures. This approach rapidly decreased TRACP-5b levels and arrested the chain of vertebral fractures. We concluded that to maintain the quality of life of patients with CUA, early treatment of primary skin lesions as well as comorbid conditions is essential. |
DOI | 10.1093/jbmrpl/ziae154 |
PMID | 39697523 |